Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Reviva Pharmaceuticals Holdings

Market Cap: US$67.3m

A biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.

Indivior

Market Cap: US$4.4b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Legend Biotech

Market Cap: US$3.9b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Galectin Therapeutics

Market Cap: US$397.2m

A clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases.

Planet 13 Holdings

Market Cap: CA$96.0m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Olema Pharmaceuticals

Market Cap: US$2.4b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Biogen

Market Cap: US$24.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Royalty Pharma

Market Cap: US$22.2b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Medpace Holdings

Market Cap: US$15.8b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Zevra Therapeutics

Market Cap: US$456.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Arcutis Biotherapeutics

Market Cap: US$3.4b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Citius Oncology

Market Cap: US$95.2m

Focuses on the development and commercialization of innovative targeted oncology therapies.

Syndax Pharmaceuticals

Market Cap: US$1.8b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Beam Therapeutics

Market Cap: US$2.6b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

ProPhase Labs

Market Cap: US$4.9m

Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.

Pyxis Oncology

Market Cap: US$107.7m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Aspen Pharmacare Holdings

Market Cap: R43.3b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

Gain Therapeutics

Market Cap: US$86.5m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Cybin

Market Cap: US$337.8m

A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Immunome

Market Cap: US$1.8b

A clinical-stage biotechnology company, develops targeted cancer therapies.

Laurus Labs

Market Cap: ₹564.2b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

Mecure Industries

Market Cap: ₦220.0b

Manufactures and sells pharmaceuticals and nutraceuticals in Nigeria.

GeoVax Labs

Market Cap: US$7.1m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

ARS Pharmaceuticals

Market Cap: US$970.7m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Lineage Cell Therapeutics

Market Cap: US$424.1m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Alnylam Pharmaceuticals

Market Cap: US$52.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Galderma Group

Market Cap: CHF 38.6b

Operates as a dermatology company worldwide.

Kiniksa Pharmaceuticals International

Market Cap: US$3.2b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Vistagen Therapeutics

Market Cap: US$29.2m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

Kura Oncology

Market Cap: US$856.3m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Radiopharm Theranostics

Market Cap: AU$72.6m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

Psyence Biomedical

Market Cap: US$2.7m

Engages in the development of botanical psilocybin-based psychedelic medicines.

GRAIL

Market Cap: US$3.4b

A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

Novavax

Market Cap: US$1.1b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Iovance Biotherapeutics

Market Cap: US$976.5m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Mirum Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.